Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals.
作者信息
Schweitzer S O, Shiota S R
机构信息
University of California School of Public Health, Los Angeles 90024.
出版信息
Annu Rev Public Health. 1992;13:399-410. doi: 10.1146/annurev.pu.13.050192.002151.
Abstract
摘要
相似文献
1
Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals.州政府对医疗补助药品报销的限制所带来的获取和成本影响。
Annu Rev Public Health. 1992;13:399-410. doi: 10.1146/annurev.pu.13.050192.002151.
2
3
States exempt psychiatric drugs in some Medicaid programs.
Manag Care. 2003 Nov;12(11):61.
4
States' control of prescription drug spending: a heterogeneous approach.各州对处方药支出的控制：一种差异化方法。
Health Aff (Millwood). 2005 Jul-Aug;24(4):1032-8. doi: 10.1377/hlthaff.24.4.1032.
5
Interest groups and state Medicaid drug programs.利益集团与州医疗补助药品计划。
J Health Polit Policy Law. 2003 Feb;28(1):9-39. doi: 10.1215/03616878-28-1-9.
6
Winners and losers. States could suffer as Congress divides the Medicaid pie.赢家与输家。随着国会分割医疗补助计划这块“蛋糕”，各州可能会受到影响。
Health Syst Rev. 1995 May-Jun;28(3):17-8.
7
Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2003.医疗补助与贫困医疗问题简报：医疗补助：医疗机构报销：2003年年终报告
Issue Brief Health Policy Track Serv. 2003 Dec 31:1-25.
8
9
Medicaid and the unconstitutional dimensions of prior authorization.
Mich Law Rev. 2002 Nov;101(2):602-47.
10
Open letter from Governor Michael F. Easley to the entire North Carolina Congressional Delegation.
N C Med J. 2005 Mar-Apr;66(2):120-1.
引用本文的文献
1
Self-restriction of medications due to cost in seniors without prescription coverage.在没有处方保险的老年人中，因费用问题自行限制用药。
J Gen Intern Med. 2001 Dec;16(12):793-9. doi: 10.1111/j.1525-1497.2001.10412.x.
Zotero 插件